Early Outcomes of Interwoven Nitinol Wire Stent Placement versus Endarterectomy for the Treatment of Atherosclerotic Disease of the Common Femoral Artery

Purpose: To compare the clinical outcomes of common femoral artery (CFA) atherosclerotic disease treated surgical endarterectomy or an interwoven nitinol wire stent system. Materials and Methods: A retrospective review was conducted of all patients with chronic, de novo atherosclerotic disease treated with surgical endarterectomy (CFAE) or stent placement between July 2019 and March 2022. measures assessed up to 12 months after procedure included clinical improvement, primary restenosis, target revascularization (TVR), major adverse limb events (MALEs), and all -cause mortality. Results: Thirty-nine stents were deployed in 33 patients, and 56 CFAEs were performed in 55 patients. No differences noted in the rate of primary patency (95.5% vs 94.4%, P = .618), TVR (2.9% vs 1.8%, P = .777), MALE (5.1% vs .949), and all -cause mortality (14.1% vs 3.6%, P = .076) between the stent and CFAE groups up to 12 months cedure. There was greater improvement in median clinical severity in the stent group than in the CFAE group score change of 3.0 vs 1.5, P = .013). The median length of stay was less for the stent group (3 vs 7 days, P there was a lower likelihood of severe or disabling adverse events in the stent group (0 vs 9 cases, P = .010). Conclusions: Patients treated with an interwoven nitinol wire stent had patency rates comparable to those CFAE while having a lower incidence of severe adverse events and a shorter length of hospital stay than underwent CFAE.